Report of Foreign Issuer (6-k)
24 Maggio 2013 - 2:33PM
Edgar (US Regulatory)
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C.
20549
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2013
Commission File Number: 000-33295
3SBIO INC.
(Translation of
registrants name into English)
No. 3 A1, Road 10
Shenyang Economy &
Technology Development Zone
Shenyang 110027
Peoples Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover Form 20-F or Form 40-F.
Form 20-F
[X] Form
40-F [ ]
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): _______
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _______
Indicate by check mark whether by furnishing the information
contained in this Form, the registrant is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the Securities
Exchange Act of 1934.
Yes [
] No
[X]
If Yes is marked, indicate below the file number assigned to
the registrant in connection with Rule 12g3-2(b): 82-
N/A
3SBio Inc. is furnishing under the cover of Form 6-K:
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
Date: May 24, 2013
By:
/s/ Dr. Jing Lou
Name: Dr. Jing Lou
Title: Chief Executive Officer
EXHIBIT INDEX
Grafico Azioni 3Sbio Inc. ADS, Each Representing Seven Ordinary Shares (MM) (NASDAQ:SSRX)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni 3Sbio Inc. ADS, Each Representing Seven Ordinary Shares (MM) (NASDAQ:SSRX)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a 3Sbio Inc. ADS, Each Representing Seven Ordinary Shares (MM) (NASDAQ): 0 articoli recenti
Più 3sbio Inc. Articoli Notizie